Analytic Investors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Analytic Investors’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-40,058	Closed	-$1.65M	–	679
2015 Q2	$1.65M	Buy	40,058 +9,975	+33%	+$358K	0.02%	306
2015 Q1	$1.06M	Hold	30,083	–	–	0.01%	358
2014 Q4	$967K	Buy	30,083 +813	+3%	+$23.5K	0.01%	356
2014 Q3	$821K	Buy	29,270 +710	+2%	+$21.6K	0.01%	399
2014 Q2	$863K	Buy	+28,560	New	+$788K	0.01%	336

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Analytic Investors's BRLI Position: Q3 2015 in Review

Analytic Investors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 40,058 shares — an estimated $1.65M sold.

Analytic Investors first reported a position in BRLI in Q2 2014 and held it in 5 quarters. The position peaked at $1.65M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Analytic Investors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Analytic Investors sold 40,058 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $1.65M.
Analytic Investors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2014 and held it in 5 quarters.
Analytic Investors's BIO-REFERENCE LABS INC-NEW- position peaked at $1.65M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Analytic Investors's 13F filing for Q3 2015, filed 12 Nov 2015.